These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29698161)

  • 1. [Not Available].
    Hyeda A; da Costa ESM
    Value Health Reg Issues; 2015 Dec; 8():107-111. PubMed ID: 29698161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation.
    Hyeda A; Costa ES
    Rev Assoc Med Bras (1992); 2015 Aug; 61(4):368-74. PubMed ID: 26466220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of dose rounding of chemotherapy to the nearest vial size.
    Dooley MJ; Singh S; Michael M
    Support Care Cancer; 2004 Sep; 12(9):653-6. PubMed ID: 14986078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system.
    Shah V; Spence A; Bartels T; Betcher J; Soefje S
    Am J Health Syst Pharm; 2022 Apr; 79(8):676-682. PubMed ID: 34940791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rounding rituximab dose to nearest vial size.
    Patel S; Le A
    J Oncol Pharm Pract; 2013 Sep; 19(3):218-21. PubMed ID: 23114093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil.
    Clark L; Castro AP; Fortes AF; Santos F; Clark O; Engel T; Pegoretti B; Teich V; Vianna D; Puty F
    Value Health; 2011; 14(5 Suppl 1):S82-4. PubMed ID: 21839906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization.
    Chillari KA; Southward J; Harrigan N
    J Oncol Pharm Pract; 2018 Oct; 24(7):507-510. PubMed ID: 28732452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APPROPRIATE DOSE ROUNDING OF CYTOKINE MODULATORS FOR PAEDIATRIC RHEUMATOLOGY INPATIENTS.
    Paget C
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer.
    Seal BS; Anderson S; Shermock KM
    J Manag Care Spec Pharm; 2016 Mar; 22(3):227-35. PubMed ID: 27003552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cost savings associated with dose rounding antineoplastic monoclonal agents.
    Francis SM; Heyliger A; Miyares MA; Viera M
    J Oncol Pharm Pract; 2015 Aug; 21(4):280-4. PubMed ID: 24821690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings.
    Jarkowski A; Nestico JS; Vona KL; Khushalani NI
    J Oncol Pharm Pract; 2014 Feb; 20(1):47-50. PubMed ID: 23512270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits associated with a broad selection of dosage strengths for recombinant factor VIII products.
    Epstein J; Xiong Y; Luo M; Li-McLeod J
    Haemophilia; 2012 Mar; 18(2):182-6. PubMed ID: 21812864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy.
    Chan A; Low XH; Yap KY
    J Manag Care Pharm; 2012 Jun; 18(5):385-94. PubMed ID: 22663171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of drug prescriptions in an adult intensive care unit.
    Cardinal Ldos S; Matos VT; Resende GM; Toffoli-Kadri MC
    Rev Bras Ter Intensiva; 2012 Jun; 24(2):151-6. PubMed ID: 23917762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
    Lokich JJ; Moore CL; Anderson NR
    Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doctor Shopping Behavior for Zolpidem Among Insomnia Patients in Taiwan: A Nationwide Population-Based Study.
    Lu TH; Lee YY; Lee HC; Lin YM
    Sleep; 2015 Jul; 38(7):1039-44. PubMed ID: 25761979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.